Work

Characterization of anti-CD79b/CD3 bispecific antibody, a potential therapy for B cell malignancies

Year: 2022

Type: article

Source: Cancer Immunology Immunotherapy

DOI: 10.1007/s00262-022-03267-5

Institutions: Innovent Biologics (China), Nanjing Medical University, Soochow University

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Innovent Biologics, Jiangsu Commission of Health, Suzhou Municipal Science and Technology Bureau

Awards: G3126107719, G8242979056

OpenAlex ID: W4291237207

FWCI: 1.795

Cites: 41

Cited by: 10

Related to: 10